Overview

Oral Tolerability Of Two Nicotine Dosage Forms

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the oral tolerability of a nicotine prototype
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Nicotine